Terms: = Lymphoma AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
60 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis.
Zhang Q; Zhu L; Zhou D; Li L; Xie W; Tan Y; Ye X
Ann Hematol; 2023 Sep; 102(9):2301-2308. PubMed ID: 37266671
[TBL] [Abstract] [Full Text] [Related]
4. Insulin Resistance and the prognosis in Diffuse Large B-cell lymphoma.
Zhou WL; Hou XJ; Liu LH; Gao Q; Feng L; Wang Y
J Coll Physicians Surg Pak; 2023 Apr; 33(4):411-415. PubMed ID: 37190713
[TBL] [Abstract] [Full Text] [Related]
5. Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia.
Zhao Y; Li C; Cai C; Fu H; Zhao Z; Han J; Zhang F; Wang J
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e739-e745. PubMed ID: 36897339
[TBL] [Abstract] [Full Text] [Related]
6. Characterisation of tumor microenvironment and prevalence of CD274/PD-L1 genetic alterations difference in colorectal Cancer.
Yang L; Liu S; He W; Xiong Z; Xia L
BMC Cancer; 2023 Mar; 23(1):221. PubMed ID: 36894899
[TBL] [Abstract] [Full Text] [Related]
7. Advanced Ann Arbor stage and age over 60 years as prognostic predictors in patients with primary cervical lymphoma: a retrospective cohort study and systematic review.
Gao L; Chen X; Zhao J; Xu A; Liu M; Yu H; Kong S; Li S
BMC Cancer; 2023 Jan; 23(1):95. PubMed ID: 36707772
[TBL] [Abstract] [Full Text] [Related]
8. Cancer incidence and mortality in Quito: information to monitor cancer control policies.
Cueva P; Tarupi W; Caballero H
Colomb Med (Cali); 2022; 53(1):e2024929. PubMed ID: 36415599
[TBL] [Abstract] [Full Text] [Related]
9. Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients.
Hashimoto K; Ariyasu R; Ichinose J; Matsuura Y; Nakao M; Amino Y; Uchibori K; Kitazono S; Yanagitani N; Okumura S; Nishio M; Mun M
J Thorac Cardiovasc Surg; 2023 Apr; 165(4):1565-1574.e1. PubMed ID: 36137840
[TBL] [Abstract] [Full Text] [Related]
10. Investigation of epidemiological characteristics and development of a nomogram to predict survival in primary ocular adnexal lymphoma.
Peng F; Su W; Zhang A; Huo B; Song T; Wei Z; Geng Z; Wang L
Clin Exp Ophthalmol; 2022 Aug; 50(6):615-631. PubMed ID: 35656846
[TBL] [Abstract] [Full Text] [Related]
11. CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies.
Bruno S; Ghelli Luserna di Rorà A; Napolitano R; Soverini S; Martinelli G; Simonetti G
J Exp Clin Cancer Res; 2022 Apr; 41(1):159. PubMed ID: 35490245
[TBL] [Abstract] [Full Text] [Related]
12. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
13. Incidence and survival trends in patients with primary tonsillar lymphoma: a large population-based study.
Liang Y; Zhang H; Wu Y; Li M
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4023-4032. PubMed ID: 35397702
[TBL] [Abstract] [Full Text] [Related]
14. [A Rare Case of Primary Splenic Malignant lymphoma Associated with Esophagogastric Junction Neuroendocrine Carcinoma(NEC)].
Fujita R; Ono HA; Tsuura Y; Yakeishi M; Kobayashi K; Daibo S; Sakai J; Suwa H; Minami Y; Nojiri K; Yosida K; Mogaki M; Masui H; Nagahori K
Gan To Kagaku Ryoho; 2022 Feb; 49(2):208-210. PubMed ID: 35249063
[TBL] [Abstract] [Full Text] [Related]
15. Clinical Characteristics and Survival Outcomes of Primary Effusion lymphoma: A National Cancer Database Study.
Baidoun F; Moustafa MA; Tun HW; Hill BT
Clin Lymphoma Myeloma Leuk; 2022 Jul; 22(7):e485-e494. PubMed ID: 35110006
[TBL] [Abstract] [Full Text] [Related]
16. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/apc/β-catenin axis.
Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
[TBL] [Abstract] [Full Text] [Related]
17. CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20.
Li F; Liu CS; Wu P; Ling AS; Pan Q; Li XN
Chin Med J (Engl); 2021 Nov; 134(22):2721-2729. PubMed ID: 34732665
[TBL] [Abstract] [Full Text] [Related]
18. The incidence, treatment and survival of patients with rare types of rectal malignancies in the Netherlands: A population-based study between 1989 and 2018.
van Rees JM; Elferink MAG; Tanis PJ; de Wilt JHW; Burger JWA; Verhoef C
Eur J Cancer; 2021 Jul; 152():183-192. PubMed ID: 34118528
[TBL] [Abstract] [Full Text] [Related]
19. Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next-Generation Sequencing are associated with disease progression in a North American Adult T-Cell Leukemia/lymphoma cohort.
Zhang X; Shi Y; Ramesh KH; Naeem R; Wang Y
Int J Lab Hematol; 2021 Aug; 43(4):651-657. PubMed ID: 33988304
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical features and treatment outcome of patients with non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis].
Sun SR; Wu M; Wulipan F; Shen L; Ma JX; Chen PP; Hu YW; Zhang HD; Xie YH
Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):324-331. PubMed ID: 33979978
[No Abstract] [Full Text] [Related]
[Next]
